Published in J Virol on June 01, 1994
Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6. EMBO J (1997) 2.96
Identification of evolutionarily conserved non-AUG-initiated N-terminal extensions in human coding sequences. Nucleic Acids Res (2011) 2.16
Design of 5' untranslated sequences in retroviral vectors developed for medical use. J Virol (1999) 1.48
Characterization of glycosylated Gag expressed by a neurovirulent murine leukemia virus: identification of differences in processing in vitro and in vivo. J Virol (1997) 1.20
Murine leukemia virus glycosylated Gag (gPr80gag) facilitates interferon-sensitive virus release through lipid rafts. Proc Natl Acad Sci U S A (2009) 1.18
Characterization of a neurologic disease induced by a polytropic murine retrovirus: evidence for differential targeting of ecotropic and polytropic viruses in the brain. J Virol (1995) 1.18
Mutation in the glycosylated gag protein of murine leukemia virus results in reduced in vivo infectivity and a novel defect in viral budding or release. J Virol (2007) 1.18
Protective efficacy of nonneutralizing monoclonal antibodies in acute infection with murine leukemia virus. J Virol (1995) 1.14
The glycosylated Gag protein of a murine leukemia virus inhibits the antiretroviral function of APOBEC3. J Virol (2010) 1.09
The neuroinvasiveness of a murine retrovirus is influenced by a dileucine-containing sequence in the cytoplasmic tail of glycosylated Gag. J Virol (1998) 1.01
Amphotropic murine leukemia viruses induce spongiform encephalomyelopathy. Proc Natl Acad Sci U S A (1997) 0.95
Brain infection by neuroinvasive but avirulent murine oncornaviruses. J Virol (2000) 0.94
N-terminal cleavage fragment of glycosylated Gag is incorporated into murine oncornavirus particles. J Virol (2001) 0.90
Moloney murine leukemia virus glyco-gag facilitates xenotropic murine leukemia virus-related virus replication through human APOBEC3-independent mechanisms. Retrovirology (2012) 0.88
The stringency of start codon selection in the filamentous fungus Neurospora crassa. J Biol Chem (2013) 0.86
Translational Initiation at a Non-AUG Start Codon for Human and Mouse Negative Elongation Factor-B. PLoS One (2015) 0.80
The cellular protein La functions in enhancement of virus release through lipid rafts facilitated by murine leukemia virus glycosylated Gag. MBio (2011) 0.78
Systematic analysis of the PTEN 5' leader identifies a major AUU initiated proteoform. Open Biol (2016) 0.75
The scanning model for translation: an update. J Cell Biol (1989) 31.23
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell (1983) 25.46
Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene (1989) 23.74
Naturally occurring murine leukemia viruses in wild mice: characterization of a new "amphotropic" class. J Virol (1976) 9.33
Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J Virol (1987) 8.81
Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of friend MCF and Friend ecotropic murine leukemia virus. Virology (1983) 4.16
Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens. Virology (1981) 3.61
A spontaneous lower motor neuron disease apparently caused by indigenous type-C RNA virus in wild mice. J Natl Cancer Inst (1973) 3.59
CUG initiation codon used for the synthesis of a cell surface antigen coded by the murine leukemia virus. J Mol Biol (1989) 3.56
Deletion mutants of Moloney murine leukemia virus which lack glycosylated gag protein are replication competent. J Virol (1983) 3.04
Hemolytic anemia and erythroleukemia, two distinct pathogenic effects of Friend MuLV: mapping of the effects to different regions of the viral genome. Cell (1986) 2.69
gag-Related polyproteins of Moloney murine leukemia virus: evidence for independent synthesis of glycosylated and unglycosylated forms. J Virol (1979) 2.68
Synthesis and glycosylation of polyprotein precursors to the internal core proteins of Friend murine leukemia virus. J Virol (1977) 2.26
A core polyprotein of murine leukemia virus on the surface of mouse leukemia cells. Cell (1976) 2.12
Lower motor neuron degeneration associated with type C RNA virus infection in mice: neuropathological features. J Neuropathol Exp Neurol (1974) 2.00
Molecular cloning of infectious viral DNA from ecotropic neurotropic wild mouse retrovirus. J Virol (1983) 1.91
Effect of dimerization on the conformation of the encapsidation Psi domain of Moloney murine leukemia virus RNA. J Mol Biol (1992) 1.89
Retrovirus-induced murine motor neuron disease: mapping the determinant of spongiform degeneration within the envelope gene. Proc Natl Acad Sci U S A (1989) 1.85
Sequence relationship of glycosylated and unglycosylated gag polyproteins of Moloney murine leukemia virus. J Virol (1980) 1.83
Physical mapping of the paralysis-inducing determinant of a wild mouse ecotropic neurotropic retrovirus. J Virol (1984) 1.82
Construction and characterization of Moloney murine leukemia virus mutants unable to synthesize glycosylated gag polyprotein. Proc Natl Acad Sci U S A (1983) 1.63
Complete nucleotide sequence of Friend murine leukemia virus, strain FB29. Nucleic Acids Res (1991) 1.61
Spongiform polioencephalomyelopathy caused by a murine retrovirus. I. Pathogenesis of infection in newborn mice. Lab Invest (1980) 1.48
Murine retrovirus-induced spongiform encephalopathy: productive infection of microglia and cerebellar neurons in accelerated CNS disease. Neuron (1991) 1.43
Horizontal transmission of murine retroviruses. J Virol (1987) 1.41
Nucleotide sequence of the gag gene and gag-pol junction of feline leukemia virus. J Virol (1984) 1.40
Age-dependent resistance to murine retrovirus-induced spongiform neurodegeneration results from central nervous system-specific restriction of virus replication. J Virol (1991) 1.26
Monoclonal antibody to the amino-terminal L sequence of murine leukemia virus glycosylated gag polyproteins demonstrates their unusual orientation in the cell membrane. J Virol (1986) 1.22
Viral determinants that control the neuropathogenicity of PVC-211 murine leukemia virus in vivo determine brain capillary endothelial cell tropism of the virus in vitro. J Virol (1993) 1.19
Retrovirus-induced spongiform myeloencephalopathy in mice: regional distribution of infected target cells and neuronal loss occurring in the absence of viral expression in neurons. Proc Natl Acad Sci U S A (1991) 1.18
The R-U5-5' leader sequence of neurovirulent wild mouse retrovirus contains an element controlling the incubation period of neurodegenerative disease. J Virol (1991) 1.17
Substitution of the U3 long terminal repeat region of the neurotropic Cas-Br-E retrovirus affects its disease-inducing potential. J Virol (1990) 1.16
Murine retrovirus-induced spongiform encephalomyelopathy: host and viral factors which determine the length of the incubation period. J Virol (1992) 1.12
Polypeptides of feline leukemia virus: a glycosylated gag-related protein is released into culture fluids. Virology (1980) 0.98
Prevention of lower limb paralysis by neutralization of type-C RNA virus in wild mice. J Natl Cancer Inst (1974) 0.98
Complete nucleotide sequence of the neurotropic murine retrovirus CAS-BR-E. Nucleic Acids Res (1991) 0.94
Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol (1993) 2.73
Enrichment of murine haemopoietic stem cells: diverging roads. Immunol Today (1989) 2.36
Early events in T-cell maturation. Annu Rev Immunol (1987) 2.27
Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family. Proc Natl Acad Sci U S A (1989) 2.24
The generation and fate of thymocytes. Semin Immunol (1990) 1.90
Molecular mechanisms of lymphocyte extravasation. I. Studies of two selective inhibitors of lymphocyte recirculation. J Immunol (1984) 1.80
CD4 expressed on earliest T-lineage precursor cells in the adult murine thymus. Nature (1991) 1.80
Inhibition of lymphocyte and neutrophil chemotaxis by pertussis toxin. J Immunol (1985) 1.56
Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice. J Virol (1992) 1.55
Expression of CD27 on murine hematopoietic stem and progenitor cells. Immunity (2000) 1.47
Murine retrovirus-induced spongiform encephalopathy: productive infection of microglia and cerebellar neurons in accelerated CNS disease. Neuron (1991) 1.43
Horizontal transmission of murine retroviruses. J Virol (1987) 1.41
Infectious entry of murine retroviruses into mouse cells: evidence of a postadsorption step inhibited by acidic pH. J Virol (1985) 1.37
Monoclonal antibodies to xenotropic and MCF murine leukemia viruses derived during the graft-versus-host reaction. Virology (1982) 1.32
Monoclonal antibodies derived during graft-versus-host reaction. II. Antibodies detect unique determinants common to many MCF viruses. Virology (1983) 1.32
Age-dependent resistance to murine retrovirus-induced spongiform neurodegeneration results from central nervous system-specific restriction of virus replication. J Virol (1991) 1.26
Characterization of glycosylated Gag expressed by a neurovirulent murine leukemia virus: identification of differences in processing in vitro and in vivo. J Virol (1997) 1.20
The R-U5-5' leader sequence of neurovirulent wild mouse retrovirus contains an element controlling the incubation period of neurodegenerative disease. J Virol (1991) 1.17
Murine retrovirus-induced spongiform encephalomyelopathy: host and viral factors which determine the length of the incubation period. J Virol (1992) 1.12
Microglial infection by a neurovirulent murine retrovirus results in defective processing of envelope protein and intracellular budding of virus particles. J Virol (1994) 1.10
Expression of Fc gamma RIII on HeLa 229 cells: possible effect on in vitro neutralization of Chlamydia trachomatis. Infect Immun (1991) 1.07
Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux. Blood (1998) 1.05
Hematopoietic stem cells: generation and self-renewal. Cell Death Differ (2007) 1.03
The neuroinvasiveness of a murine retrovirus is influenced by a dileucine-containing sequence in the cytoplasmic tail of glycosylated Gag. J Virol (1998) 1.01
Brain infection by neuroinvasive but avirulent murine oncornaviruses. J Virol (2000) 0.94
Complete nucleotide sequence of the neurotropic murine retrovirus CAS-BR-E. Nucleic Acids Res (1991) 0.94
Infectivity of retroviral DNA in vivo. J Acquir Immune Defic Syndr (1992) 0.93
Paralysis of street rabies virus-infected mice is dependent on T lymphocytes. J Virol (1992) 0.91
N-terminal cleavage fragment of glycosylated Gag is incorporated into murine oncornavirus particles. J Virol (2001) 0.90
Increased expression of MIP-1 alpha and MIP-1 beta mRNAs in the brain correlates spatially and temporally with the spongiform neurodegeneration induced by a murine oncornavirus. J Virol (2001) 0.88
Marrow engraftment of hematopoietic stem and progenitor cells is independent of Galphai-coupled chemokine receptors. Exp Hematol (1999) 0.87
Primitive stem cells alone mediate rapid marrow recovery and multilineage engraftment after transplantation. Bone Marrow Transplant (1998) 0.86
Alterations in lymphocyte homing patterns within mice exposed to ultraviolet radiation. J Immunol (1983) 0.84
A simplified rapid method for purification of glomeruli. J Clin Pathol (1979) 0.84
Prevention of retrovirus-induced neurological disease by infection with a nonneuropathogenic retrovirus. Virology (1995) 0.84
Correlation between keratinocyte expression of Ia and the intensity and duration of contact hypersensitivity responses in mice. J Immunol (1985) 0.84
Maturation of hematolymphoid cells that express Thy-1. Immunol Ser (1989) 0.83
Molecular mechanisms of lymphocyte extravasation. II. Studies of in vitro lymphocyte adherence to high endothelial venules. J Immunol (1984) 0.82
Rapid, B lymphoid-restricted engraftment mediated by a primitive bone marrow subpopulation. J Immunol (2000) 0.81
High-frequency cell surface expression of a foreign protein in murine hematopoietic stem cells using a new retroviral vector. Blood (1996) 0.81
Modulation of hematopoietic stem/progenitor cell engraftment by transforming growth factor beta. Exp Hematol (2000) 0.81
Inhibitory effects of various oxygenated sterols on the differentiation and function of tumor-specific cytotoxic T lymphocytes. Transplantation (1982) 0.81
Studies on the liver sequestration of lymphocytes bearing membrane-associated galactose-terminal glycoconjugates: reversal with agents that effectively compete for the asialoglycoprotein receptor. Cell Immunol (1984) 0.81
Patterns of organ-specific engraftment by stem cell subsets and committed progenitors. Stem Cells (1997) 0.80
Dissociation of H-2 recognition by antibody and cytotoxic T cells of a cloned murine leukemia cell line. Immunogenetics (1981) 0.79
The degree of folding instability of the envelope protein of a neurovirulent murine retrovirus correlates with the severity of the neurological disease. J Virol (2009) 0.79
Site-selective homing of antigen-primed lymphocyte populations can play a crucial role in the efferent limb of cell-mediated immune responses in vivo. J Immunol (1985) 0.79
Phenotypic distinction and functional characterization of pro-B cells in adult mouse bone marrow. J Immunol (2001) 0.78
Production and characterization of new monoclonal antibodies that distinguish subsets of mink lymphoid cells. Hybridoma (1994) 0.78
Regulation by the skin of lymphoid cell recirculation and localization properties. J Invest Dermatol (1985) 0.77
Direct effects of cyclosporin A on proliferation of hematopoietic stem and progenitor cells. Cell Transplant (1999) 0.76
PGM-1: a transplantable murine leukemia of granulocyte-macrophage progenitor cells. Leukemia (1989) 0.75
(R)evolutionary considerations in hematopoietic development. Ann N Y Acad Sci (1999) 0.75
Observations of residual differentiation potential during lineage commitment. Ann N Y Acad Sci (2001) 0.75
The interplay of microbes and their hosts. Immunol Today (1992) 0.75
Description of and treatment to inhibit the rejection of human split-thickness skin grafts by congenitally athymic (nude) rats. Exp Cell Biol (1986) 0.75